Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Ai2 Ltd logo — company profile

Ai2 Ltd

Founded 2005 United Kingdom Manchester, United Kingdom 3 employees Venture round Total: $2.00M Biopharma, Biotechnology +1

General Information

Company Name Ai2 Ltd
Founded Year 2005
Location United Kingdom Manchester, United Kingdom
Employees 3
Industries Biopharma, Biotechnology, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Ai2 Ltd. To contact Ai2 Ltd, visit a-i-2.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ai2 Ltd compare?

A PDF of Ai2 Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ai2 Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ai2 Ltd

Ai2 Ltd is a UK-based biotechnology company that specializes in novel anti-infective peptide technology. Founded in 2005, Ai2 aims to develop this technology for diverse health and personal care applications where the combination of efficacy and safety that it offers will provide significant benefits. The company operates in the Biopharma and Biotechnology industries and received a £1.75M Venture Round investment on 06 January 2012 from The North West Fund, MTI Ventures, and SPARK Impact. Ai2 Ltd offers a cutting-edge solution with potent broad-spectrum activity and an excellent safety profile, catering to the increasing demand for innovative antimicrobial technologies in various sectors. Its investment history and mission to revolutionize the healthcare and personal care sectors make it a promising prospect for venture capital firms seeking impactful and sustainable opportunities in the biotechnology space.

Business keywords: anti-infective, peptide technology, broad-spectrum activity, safety profile, health applications, personal care applications, efficacy, safety benefits

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £1.75M 3
The North West Fund MTI Ventures
The North West Fund, MTI Ventures +1
06 Jan 2012
Venture Round £250.00K 1
MTI Ventures
MTI Ventures
29 Jan 2010

Ai2 Ltd Alternatives & Competitors

View All Alternatives
Ai2 Ltd vs
Topica Pharmaceuticals
Topica Pharmaceuticals

Developing the first highly effective and safe topical therapy for onychomycosis.

Venture round
Biotechnology, Medical Devices
Ai2 Ltd vs
Solius Labs
Solius Labs United States

SOLIUS® Medical Light Therapy

Series B
33 employees
Biotechnology, Health Care
Ai2 Ltd vs
Lutonix, Inc.
Lutonix, Inc. United States

Delivering precision and safety in every inflation for optimal arterial health

Acquired
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About Ai2 Ltd

Ai2 Ltd is a UK-based biotechnology company that specialises in novel anti-infective peptide technology that combines potent broad-spectrum activity with an excellent safety profile. Founded in 2005 Ai2 aims to develop this technology for diverse health and personal care applications where the co...
Ai2 Ltd was founded in 2005.
Ai2 Ltd is headquartered in Manchester, United Kingdom.
Ai2 Ltd operates in Biopharma, Biotechnology and Medical Devices. Its work centres on anti-infective, peptide technology, broad-spectrum activity and safety profile.
Ai2 Ltd has approximately 3 employees.
Ai2 Ltd has completed 2 funding rounds, raising a total of $2.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Ai2 Ltd include Topica Pharmaceuticals, Solius Labs, Lutonix, Inc., Healx, EarlySense. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ai2 Ltd and Topica Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ai2 Ltd, https://bouncewatch.com/company/ai2-ltd, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes